Navigation Links
San Diego Based CRO Signs Agreement With UK Based Spinal Device Manufacturer

SAN DIEGO, March 16 /PRNewswire/ -- SpineMark CRO Management, a wholly-owned subsidiary of San Diego based SpineMark Corporation, recently signed an agreement with Ranier Technology, a Cambridge, England based spinal medical device manufacturer, to provide contract research support services for the Ranier CAdisc™-L clinical trial, a 3rd generation lumbar total disc replacement device for treatment of degenerative disc disease in the lumbar spine.  SpineMark CRO Management provides site recruitment including utilization of principal investigators from its network of sites, reimbursement strategy development, payor education, trial management, site training, patient recruitment, data management, monitoring, regulatory advice and general oversight to allow Ranier to effectively complete their FDA requirements for approval of new spinal devices.  

"The SpineMark CRO model provides intermediary third party oversight to ensure that the highest quality of monitoring, management and resources can be brought to bear for Ranier, as well as the patients and physicians participating in this trial," explains Marcy Rogers, President and CEO of SpineMark.

The CAdisc™-L design, materials and biomechanics represent a significant clinical advance in the treatment of degenerative disc disease in the lumbar spine.  

"I am delighted to be working with SpineMark. Their specialized dedication to clinical research in spine, their relationships, and their ability to manage various aspects of the US clinical trial process makes them a perfect fit for our study," explains Dr. Geoffrey Andrews, CEO of Ranier Technology.

SpineMark offers an international medical advisory board and access to SpineMark's network of leading physicians and surgeons across the country. The corporation is an expert in FDA regulations and protocol, offering site operations support and training, contract negotiation and financial management, regulatory and compliance oversight and marketing and media relations.  

For more information on SpineMark CRO Management visit

For more information on Ranier Technology Limited visit

SOURCE SpineMark Corporation

Back to top



SOURCE SpineMark Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
2. PG500 Series Presented at the AACR Annual Meeting in San Diego
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
6. Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego
7. Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego
8. Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line
9. California American Water Celebrates No Drugs Down the Drain Week in San Diego
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... PRMA Plastic ... November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , ... wake up every day excited to rebuild lives and it’s an honor to have ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings Final ... ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, ... giving users limitless opportunities to stylize and create designs quickly and easily, all ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
Breaking Medicine News(10 mins):